Buffered Anesthetic Solution in the Treatment of Mandibular Primary Molars
Evaluation of the Effect of Buffered Anesthetic Solution (Lidocaine 2%) in the Effectiveness of Inferior Alveolar Nerve Block Injection During the Treatment of Mandibular Primary Molars
1 other identifier
interventional
40
1 country
1
Brief Summary
In a prospective, randomized clinical trial, triple-blind, split-mouth study, 40 children aged between 7 to 10 with bilateral mandibular primary molars were diagnosed with pulpitis. The test agent was 2% lidocaine with 1:80.000 epinephrine buffered with sodium bicarbonate 8.4% at a ratio of 1/10, as opposed to the control agent, which was non- buffered 2% lidocaine with 1:80,000 epinephrine. The pain will be assessed during inferior alveolar nerve block injection (IANB) and the effectiveness of anesthesia using the subjective Wong-Baker visual analog scale, the objective sound, eye, and motor (SEM) scale, and the physiological pain scale (pulse rate) using a pulse oximeter. The investigator has confirmed the onset of anesthesia after lip tongue-numbing by probing the gingiva until there is no pain. Endo-ice has been used to assess the onset of pulp anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Dec 2022
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedFirst Posted
Study publicly available on registry
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 3, 2023
CompletedSeptember 29, 2023
September 1, 2023
3 months
February 7, 2023
September 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Probing the gingiva
The onset of anaesthesia at soft tissue will be assessed by probing the gingiva After IANB injection.
directly after asking the child about lip, tongue numbing every 30 seconds until there is no pain.
Endo - ice test
The investigator will use endo-ice to assess the onset time of pulp anaesthesia.
Every 30 seconds after confirmed soft tissues anaesthesia until the absence of pain.
Pulse rate
Pulse rate is a physiological pain scale which will be taken through a finger pulse oximeter.
A minute before anaesthesia.
Pulse rate
Pulse rate is a physiological pain scale, will be taken through a finger pulse oximeter.
20 seconds after the first quarter of the local anaesthesia.
Wong baker faces scale.
Wong Baker faces scale is a subjective pain which contains a series of six faces ranging from a happy face at 0 to indicate "no hurt" to a crying face at 10 to indicate "hurts worst"
One minute after IANB injection
Sound, eye, motor scale (SEM)
Sound, eye, motor scale is an objective pain scale for the assessment of child's behaviour by recording video during anaesthesia
Within five seconds from the start of the local anesthetic injection to completion
Secondary Outcomes (3)
Pulse rate
20 seconds after opening the pulp chamber
Wong baker faces scale
one minute after preparing pulp chamber
sound, eye, motor scale (SEM)
Within five seconds from the start of the local anaesthetic injection to completion
Study Arms (2)
Buffered lidocaine
EXPERIMENTALInferior alveolar nerve block with buffered anesthetic solution (2% lidocaine with 1/80000 adrenaline mixed with sodium bicarbonate 8.4%)
Lidocaine 2%
OTHERControl group: Inferior alveolar nerve block with anesthetic solution (Lidocaine 2% with adrenaline 1.80000).
Interventions
Buffered Lidocaine 2% with epinephrine 1.80000 mixed with 1.8% sodium bicarbonate in IANB injection in the treatment of bilateral primary mandibular molars
Lidocaine 2% with epinephrine 1.80000 in IANB injection in the treatment of bilateral primary mandibular molars
Eligibility Criteria
You may qualify if:
- Children who are healthy and free of any underlying conditions that might make local anesthesia impossible to administer.
- Children that are not allergic to (lidocaine, adrenaline, or sodium bicarbonate).
- Children aged 6-10 years old
- Cooperative children on Frankel scale (positive or absolute positive).
- children needing bilateral (right and left) endodontic treatment for the mandibular primary molars.
- A positive outcome on the cold test for the target tooth.
You may not qualify if:
- Uncooperative children on Frankel's scale (passive or absolute positive).
- The presence of a fistula.
- The presence of an abscess associated with the target tooth.
- The presence of a periapical lesion radially.
- Negative response to the cold test.
- Children suffering from systemic conditions.
- Children who are allergic to (lidocaine, adrenaline, sodium bicarbonate).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of dentistry.
Damascus, Al-Mazzeh Saint, Damascus P.O.Box 3062, Syria
Related Publications (4)
Chopra R, Jindal G, Sachdev V, Sandhu M. Double-Blind Crossover Study to Compare Pain Experience During Inferior Alveolar Nerve Block Administration Using Buffered Two Percent Lidocaine in Children. Pediatr Dent. 2016 Jan-Feb;38(1):25-9.
PMID: 26892211RESULTGoodchild JH, Donaldson M. Novel Direct Injection Chairside Buffering Technique for Local Anesthetic Use in Dentistry. Compend Contin Educ Dent. 2019 Jul/Aug;40(7):e1-e10.
PMID: 31478693RESULTMeincken M, Norman C, Arevalo O, Saman DM, Bejarano T. Anesthesia Onset Time and Injection Pain Between Buffered and Unbuffered Lidocaine Used as Local Anesthetic for Dental Care in Children. Pediatr Dent. 2019 Sep 15;41(5):354-357.
PMID: 31648665RESULTKurien RS, Goswami M, Singh S. Comparative evaluation of anesthetic efficacy of warm, buffered and conventional 2% lignocaine for the success of inferior alveolar nerve block (IANB) in mandibular primary molars: A randomized controlled clinical trial. J Dent Res Dent Clin Dent Prospects. 2018 Spring;12(2):102-109. doi: 10.15171/joddd.2018.016. Epub 2018 Jun 20.
PMID: 30087760RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chaza Kouchaji, Professor
Supervisal
- STUDY DIRECTOR
Hanadi Almattit, Phd,lecturer
Co- supervisal
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Triple Masking: Patients, Investigators and Statistician
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2023
First Posted
March 31, 2023
Study Start
December 1, 2022
Primary Completion
March 1, 2023
Study Completion
April 3, 2023
Last Updated
September 29, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share